Lykos Therapeutics
Inspiring Change In Mental Healthcare
United States · $150.0M raised
- Business Model
- B2B2C
- Website
- lykospbc.com
- Total Funding
- $150.0M
- Last Round
- $50.0M Series BMay 2025
- Rounds
- 2
About
Lykos Therapeutics develops prescription psychedelics for mental health treatment, focusing on PTSD.
Summary
Lykos Therapeutics is a Biotech company based in United States. It has raised $150.0M in total across 2 rounds, most recently a $50.0M Series B round in May 2025. Investors include Helena, True Ventures and Kittyhawk Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company